Status:
COMPLETED
Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic AF
Lead Sponsor:
CardioFocus
Conditions:
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the safety and effectiveness of the endoscopic ablation system - adaptive contact (EAS-AC) in treated paroxysmal atrial fibrillation (PAF) with pulmonary vein...
Eligibility Criteria
Inclusion
- Symptomatic, Paroxysmal atrial fibrillation (AF)
- 18 to 70 years of age
- Failure of at least one AAD
- Others
Exclusion
- Generally good overall health as determined by multiple criteria
- Willing to participate in a study
- Others
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT00958165
Start Date
August 1 2009
End Date
May 1 2012
Last Update
August 30 2016
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardioangiologisches Centrum Bethanien - CCB
Frankfurg, Germany, 60431
2
St. Georg Hosptial
Hamburg, Germany, 20099
3
Universität Leipzig - Herzzentrum
Leipzig, Germany, 04289